# Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain

> **NCT00595530** · PHASE2 · TERMINATED · sponsor: **Connecticut Children's Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** ketamine

## Key facts

- **NCT ID:** NCT00595530
- **Lead sponsor:** Connecticut Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03-04
- **Primary completion:** 2010-02-12
- **Final completion:** 2010-02-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Lack of enrollment and patient interest in study
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595530, "Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00595530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*